Kyle has a degree in Film, Television, and Cultural Studies and has loved video games for as long as he can remember. He's owned every PlayStation, dabbled with the occasional Xbox, and even owned a ...

Jess Loren remembers loving the taste of Cap'n Crunch cereal. Coca-Cola. Snickers bars. But now, instead of a sweetness, "they taste bland," she says. Flavors are noticeably muted since she started a ...

There are various ways of getting gear, but outside of raiding, exchanging your hard earned Tomestones if the best.

As GLP-1s grow in popularity, more Americans are rethinking weight loss in the new year KIRKLAND, Wash, Dec. 19, 2025 /PRNewswire/ -- A new survey from Sunlight.com finds that interest in GLP-1 ...

KIRKLAND, Wash, Dec. 19, 2025 /PRNewswire/ -- A new survey from Sunlight.com finds that interest in GLP-1 medications is rising as Americans set weight-loss goals for 2026. The December 2025 survey of ...

Forbes contributors publish independent expert analyses and insights. Hugh McIntyre covers music, with a focus on the global charts. Aerosmith and Yungblud debut “Wild Woman” at No. 1 on the Rock ...

It’s beginning to look a lot like “Selfie szn.” Kim Kardashian can be seen soaking up the sun in a tiny leopard print string bikini in her latest Instagram photo dump shared on Tuesday. In the picture ...

Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences those businesses and shapes what we all pay for care. He is also ...

In 2025, India witnessed a significant shift in obesity management with the launch of GLP-1 receptor agonists (GLP-1s), a class of medications primarily used to manage diabetes and facilitate weight ...

Most people try to improve AI responses by rewriting their prompt. I tried one simple follow-up instead — and it changed ...

Few medications have had such a meteoric rise as semaglutide (Ozempic, Wegovy) and tirzepatide (Zepbound), the GLP-1-based treatments for obesity that have captivated society and quickly become ...

If your doctor recommended you start taking a glucagon-like peptide-1 (GLP-1) receptor agonist like semaglutide to help manage your metabolic dysfunction-associated steatohepatitis (MASH), you likely ...